Modified ice study: A phase II study of an intensive, modified ICE regimen (ifosfamide, carboplatin and etoposide) in patients with better prognosis, small cell lung cancer

This publication has 18 references indexed in Scilit:

• Carcinoma of the bronchus in the Yorkshire region of England 1976-1990: trends since 1984
  European Respiratory Journal, 1997
• Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial
  The Lancet, 1996
• Ifosfamide, carboplatin and etoposide for good prognosis small cell lung cancer: are four courses inadequate?
  European Journal Of Cancer, 1995
• Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation
  European Journal Of Cancer, 1994
• Ifosfamide/carboplatin/etoposide (ICE) regimen in small cell lung cancer
  Lung Cancer, 1993
• A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.
  Journal of Clinical Oncology, 1989
• Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer
  British Journal of Cancer, 1989
• Cisplatin and etoposide (VP-16) as a single regimen for small cell lung cancer. A phase II trial
  Cancer, 1989
• Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer: Report to the medical research council by its lung cancer working party
  Respiratory Medicine, 1989
• Psychosocial well-Being of Patients with Inoperable Non-Small Cell Lung Cancer: The importance of treatment- and disease-related factors
  Acta Oncologica, 1988